{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"pt-141-insomnia","title":"PT-141 for Insomnia: Evidence-Graded Review","body":"## What's breaking down\nInsomnia involves disrupted sleep-wake regulation. The hypothalamus helps control both sexual arousal and sleep cycles through shared pathways. When CNS arousal signals stay elevated or misfire at night, falling or staying asleep becomes harder. No single peptide fixes this directly. Repair would mean restoring balanced signaling in those brain regions rather than forcing sedation.\n\n## Why PT-141 might help you\nPT-141 activates melanocortin receptors (mainly MC4R) in the hypothalamus. This is the same area that processes both sexual motivation and aspects of arousal state.\n\n1. If your insomnia links to under-arousal or flattened motivation during the day that flips into nighttime restlessness, the CNS arousal layer is one possible contributor.\n2. PT-141 is discussed for that layer because it engages central pathways rather than acting as a sedative or masking symptoms.\n3. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue/CNS signaling balance) — not because it masks pain or forces sleep.\n\nHuman data for insomnia itself does not exist. All clinical work focused on sexual desire.\n\n## How these fit together\nSingle-compound focus. PT-141 targets the sexual / CNS arousal layer only. If your insomnia profile involves other layers (hormonal, inflammatory, or mechanical), additional compounds would address those separately.\n\n## What the evidence actually shows\nNo randomized trials tested PT-141 for insomnia. Phase 3 RECONNECT trials (two identical studies, ~1,200+ premenopausal women) measured sexual desire and distress scores over 24 weeks. They showed statistically significant improvements in desire domain scores versus placebo but reported no sleep endpoints (source: pubmed.ncbi.nlm.nih.gov/31599840, clinicaltrials.gov NCT02338960 and NCT02333071).\n\nSide-effect data from the same program lists “trouble sleeping” as a possible reaction (mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route).\n\n## What scientists say\nResearchers describe PT-141 as a melanocortin agonist acting centrally on MC3R/MC4R in the hypothalamus. This mechanism explains effects on sexual motivation. No publications link it to sleep architecture or insomnia treatment. Hypothalamic melanocortin pathways overlap with arousal regulation, but that overlap remains untested for sleep outcomes.\n\n## What people say on Reddit\nAnecdotal reports are mixed and sparse. One thread titled “PT-141 and best sleep ever” describes subjectively deeper rest after dosing. Several users note fatigue or 10–12 hours of sleep the night after injection, sometimes with persistent arousal effects upon waking. Others report restlessness or nausea that interferes with sleep. No consistent pattern of insomnia relief appears across threads (examples: reddit.com/r/Peptidesource/comments/1qdmtus, reddit.com/r/erectiledysfunction/comments/15cmlf0).\n\n## What people say on X\nLimited public discussion. Posts mentioning PT-141 and sleep are rare and usually incidental to libido use. No verified threads or threads with measurable outcomes surfaced in searches.\n\n## What we do not know\n- Whether PT-141 changes sleep latency, efficiency, or architecture in humans.\n- Dose-response relationship for any sleep effect.\n- Long-term impact on insomnia when used repeatedly.\n- Interaction with common insomnia factors such as cortisol rhythm or circadian misalignment.\nAll claims beyond the established sexual-desire indication remain mechanistic or anecdotal.\n\n## Safety and limits\nCommon side effects in trials included nausea, flushing, and headache. “Trouble sleeping” appears in prescribing information. PT-141 carries an FDA approval only for hypoactive sexual desire disorder in premenopausal women. No safety data support its use for insomnia. Individual responses vary widely in anecdotal reports.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/pt-141-insomnia/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No randomized controlled trials have tested PT-141 (bremelanotide) for insomnia or sleep improvement.","section":"What the evidence actually shows","tier":"human","source_ids":["s1","s2"],"source_status":"sourced","why_material":"Establishes absence of direct evidence for the claimed use.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:14:09.291Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Phase 3 RECONNECT trials showed statistically significant improvements in sexual desire scores versus placebo in women with HSDD.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Provides the actual approved indication and strength of evidence.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:14:09.291Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Prescribing information lists trouble sleeping as a possible side effect of bremelanotide.","section":"Safety and limits","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Direct safety signal relevant to insomnia discussion.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":"limitations","who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:14:09.291Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"PT-141 acts as an MC4R agonist in the hypothalamus, a region involved in both sexual arousal and broader arousal state regulation.","section":"Why PT-141 might help you","tier":"mechanistic","source_ids":["s4"],"source_status":"sourced","why_material":"Explains the proposed CNS layer without claiming clinical effect.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:14:09.291Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"Some Reddit users report subjectively improved or prolonged sleep after PT-141 dosing, while others report restlessness or fatigue.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s5","s6"],"source_status":"sourced","why_material":"Documents real-world user observations separate from trials.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:14:09.291Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/31599840/","title":"Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials","quote":"Both studies demonstrated that bremelanotide significantly improved sexual desire and related distress in premenopausal women with hypoactive sexual desire disorder.","summary":"Phase 3 RECONNECT trial results for HSDD; no sleep endpoints reported.","claim_ids":["c1","c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:14:08.815Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"814839b477804ad6c66c888aa86822c1584adb56fec72567a04b0381e73cfd27"},{"id":"s2","type":"clinical_trial","url":"https://clinicaltrials.gov/study/NCT02338960","title":"Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder","quote":"Primary Objective: To evaluate the efficacy of bremelanotide (BMT)... for the treatment of HSDD","summary":"Confirms trial design focused solely on sexual desire.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:14:08.815Z","link_status":"ok","quote_status":"unverified","prev":"814839b477804ad6c66c888aa86822c1584adb56fec72567a04b0381e73cfd27","hash":"3ff336a1821e343c0f352debdbe559b93fcf0dc503cc4932367a1dc961887cd3"},{"id":"s3","type":"medical","url":"https://www.mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route/description/drg-20466805","title":"Bremelanotide (subcutaneous route) - Side effects & dosage","quote":"* trouble sleeping","summary":"Lists trouble sleeping among possible side effects.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:14:08.815Z","link_status":"http_403","quote_status":"unverified","prev":"3ff336a1821e343c0f352debdbe559b93fcf0dc503cc4932367a1dc961887cd3","hash":"5abe74d91d95c0be2c607b4f6b49b53b5c9205e9aa92791d26d5ff6d275a2192"},{"id":"s4","type":"review","url":"https://www.innerbalance.com/p/learn/pt141-for-women/","title":"PT-141 for Women: Complete Guide to Bremelanotide","quote":"PT-141 targets the central nervous system directly, addressing desire at its neurological origin.","summary":"Describes hypothalamic MC4R mechanism.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:14:08.815Z","link_status":"http_429","quote_status":"unverified","prev":"5abe74d91d95c0be2c607b4f6b49b53b5c9205e9aa92791d26d5ff6d275a2192","hash":"07ba452e51ea1a434dda8d37c0f0af9dc20e102d2e211011f71e4be5fc511e2d"},{"id":"s5","type":"reddit","url":"https://www.reddit.com/r/Peptidesource/comments/1qdmtus/pt141_and_best_sleep_ever/","title":"PT-141 and best sleep ever","quote":"PT-141 is great and I take it every 3 days... the effects last...","summary":"User anecdote claiming improved sleep.","claim_ids":["c5"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:14:08.815Z","link_status":"ok","quote_status":"unverified","prev":"07ba452e51ea1a434dda8d37c0f0af9dc20e102d2e211011f71e4be5fc511e2d","hash":"d73163b5dd1d7a9b40781c70389c30730d391440af9d2adf6f6b4f586baf7da2"},{"id":"s6","type":"reddit","url":"https://www.reddit.com/r/erectiledysfunction/comments/15cmlf0/pt141_works_great_but_only_when_sleeping/","title":"PT141 works great but only when sleeping","quote":"I always sleep 12 hours straight after taking it.","summary":"Multiple user reports of altered sleep duration or quality.","claim_ids":["c5"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:14:08.815Z","link_status":"ok","quote_status":"unverified","prev":"d73163b5dd1d7a9b40781c70389c30730d391440af9d2adf6f6b4f586baf7da2","hash":"68b103dde713d10ee3d4549f43841e986c67e735b1ee09fe14e8d6b7f9a3137f"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T01:14:09.941Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"PT-141 for Insomnia: Evidence-Graded Review","register":"source_ledger","body":"## What's breaking down\nInsomnia involves disrupted sleep-wake regulation. The hypothalamus helps control both sexual arousal and sleep cycles through shared pathways. When CNS arousal signals stay elevated or misfire at night, falling or staying asleep becomes harder. No single peptide fixes this directly. Repair would mean restoring balanced signaling in those brain regions rather than forcing sedation.\n\n## Why PT-141 might help you\nPT-141 activates melanocortin receptors (mainly MC4R) in the hypothalamus. This is the same area that processes both sexual motivation and aspects of arousal state.\n\n1. If your insomnia links to under-arousal or flattened motivation during the day that flips into nighttime restlessness, the CNS arousal layer is one possible contributor.\n2. PT-141 is discussed for that layer because it engages central pathways rather than acting as a sedative or masking symptoms.\n3. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue/CNS signaling balance) — not because it masks pain or forces sleep.\n\nHuman data for insomnia itself does not exist. All clinical work focused on sexual desire.\n\n## How these fit together\nSingle-compound focus. PT-141 targets the sexual / CNS arousal layer only. If your insomnia profile involves other layers (hormonal, inflammatory, or mechanical), additional compounds would address those separately.\n\n## What the evidence actually shows\nNo randomized trials tested PT-141 for insomnia. Phase 3 RECONNECT trials (two identical studies, ~1,200+ premenopausal women) measured sexual desire and distress scores over 24 weeks. They showed statistically significant improvements in desire domain scores versus placebo but reported no sleep endpoints (source: pubmed.ncbi.nlm.nih.gov/31599840, clinicaltrials.gov NCT02338960 and NCT02333071).\n\nSide-effect data from the same program lists “trouble sleeping” as a possible reaction (mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route).\n\n## What scientists say\nResearchers describe PT-141 as a melanocortin agonist acting centrally on MC3R/MC4R in the hypothalamus. This mechanism explains effects on sexual motivation. No publications link it to sleep architecture or insomnia treatment. Hypothalamic melanocortin pathways overlap with arousal regulation, but that overlap remains untested for sleep outcomes.\n\n## What people say on Reddit\nAnecdotal reports are mixed and sparse. One thread titled “PT-141 and best sleep ever” describes subjectively deeper rest after dosing. Several users note fatigue or 10–12 hours of sleep the night after injection, sometimes with persistent arousal effects upon waking. Others report restlessness or nausea that interferes with sleep. No consistent pattern of insomnia relief appears across threads (examples: reddit.com/r/Peptidesource/comments/1qdmtus, reddit.com/r/erectiledysfunction/comments/15cmlf0).\n\n## What people say on X\nLimited public discussion. Posts mentioning PT-141 and sleep are rare and usually incidental to libido use. No verified threads or threads with measurable outcomes surfaced in searches.\n\n## What we do not know\n- Whether PT-141 changes sleep latency, efficiency, or architecture in humans.\n- Dose-response relationship for any sleep effect.\n- Long-term impact on insomnia when used repeatedly.\n- Interaction with common insomnia factors such as cortisol rhythm or circadian misalignment.\nAll claims beyond the established sexual-desire indication remain mechanistic or anecdotal.\n\n## Safety and limits\nCommon side effects in trials included nausea, flushing, and headache. “Trouble sleeping” appears in prescribing information. PT-141 carries an FDA approval only for hypoactive sexual desire disorder in premenopausal women. No safety data support its use for insomnia. Individual responses vary widely in anecdotal reports.","claims":[{"id":"c1","text":"No randomized controlled trials have tested PT-141 (bremelanotide) for insomnia or sleep improvement.","section":"What the evidence actually shows","tier":"human","source_ids":["s1","s2"],"source_status":"sourced","why_material":"Establishes absence of direct evidence for the claimed use.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:14:09.291Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Phase 3 RECONNECT trials showed statistically significant improvements in sexual desire scores versus placebo in women with HSDD.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Provides the actual approved indication and strength of evidence.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:14:09.291Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Prescribing information lists trouble sleeping as a possible side effect of bremelanotide.","section":"Safety and limits","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Direct safety signal relevant to insomnia discussion.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":"limitations","who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:14:09.291Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"PT-141 acts as an MC4R agonist in the hypothalamus, a region involved in both sexual arousal and broader arousal state regulation.","section":"Why PT-141 might help you","tier":"mechanistic","source_ids":["s4"],"source_status":"sourced","why_material":"Explains the proposed CNS layer without claiming clinical effect.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:14:09.291Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"Some Reddit users report subjectively improved or prolonged sleep after PT-141 dosing, while others report restlessness or fatigue.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s5","s6"],"source_status":"sourced","why_material":"Documents real-world user observations separate from trials.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:14:09.291Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/31599840/","title":"Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials","quote":"Both studies demonstrated that bremelanotide significantly improved sexual desire and related distress in premenopausal women with hypoactive sexual desire disorder.","link_status":"ok","quote_status":"verified"},{"id":"s2","type":"clinical_trial","url":"https://clinicaltrials.gov/study/NCT02338960","title":"Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder","quote":"Primary Objective: To evaluate the efficacy of bremelanotide (BMT)... for the treatment of HSDD","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"medical","url":"https://www.mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route/description/drg-20466805","title":"Bremelanotide (subcutaneous route) - Side effects & dosage","quote":"* trouble sleeping","link_status":"http_403","quote_status":"unverified"},{"id":"s4","type":"review","url":"https://www.innerbalance.com/p/learn/pt141-for-women/","title":"PT-141 for Women: Complete Guide to Bremelanotide","quote":"PT-141 targets the central nervous system directly, addressing desire at its neurological origin.","link_status":"http_429","quote_status":"unverified"},{"id":"s5","type":"reddit","url":"https://www.reddit.com/r/Peptidesource/comments/1qdmtus/pt141_and_best_sleep_ever/","title":"PT-141 and best sleep ever","quote":"PT-141 is great and I take it every 3 days... the effects last...","link_status":"ok","quote_status":"unverified"},{"id":"s6","type":"reddit","url":"https://www.reddit.com/r/erectiledysfunction/comments/15cmlf0/pt141_works_great_but_only_when_sleeping/","title":"PT141 works great but only when sleeping","quote":"I always sleep 12 hours straight after taking it.","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":15126,"tokens_out":2920,"cost":0.0262075,"prev_hash":"genesis","hash":"0886d4050077d04d8711e72f73c273cee83a360db0c2ac4fc33445fe771caa95"}],"provenance":[{"ts":"2026-06-30T01:14:09.941Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: PT 141 for Insomnia\nSlug: pt-141-insomnia\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"pt-141\",\"name\":\"PT-141\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"pt-141\",\"name\":\"PT-141\",\"section_title\":\"Why PT-141 might help you\",\"layer\":\"sexual / CNS arousal\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **PT-141** → sexual / CNS arousal\",\"section_headings\":[\"What's breaking down\",\"Why PT-141 might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one peptide essay.\",\"Each Why section must use if-then steps from peptide","response":"{\n  \"slug\": \"pt-141-insomnia\",\n  \"title\": \"PT-141 for Insomnia: Evidence-Graded Review\",\n  \"body\": \"## What's breaking down\\nInsomnia involves disrupted sleep-wake regulation. The hypothalamus helps control both sexual arousal and sleep cycles through shared pathways. When CNS arousal signals stay elevated or misfire at night, falling or staying asleep becomes harder. No single peptide fixes this directly. Repair would mean restoring balanced signaling in those brain regions rather than forcing sedation.\\n\\n## Why PT-141 might help you\\nPT-141 activates melanocortin receptors (mainly MC4R) in the hypothalamus. This is the same area that processes both sexual motivation and aspects of arousal state.\\n\\n1. If your insomnia links to under-arousal or flattened motivation during the day that flips into nighttime restlessness, the CNS arousal layer is one possible contributor.\\n2. PT-141 is discussed for that layer because it engages central pathways rather than acting as a sedative or masking symptoms.\\n3. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue/CNS signaling balance) — not because it masks pain or forces sleep.\\n\\nHuman data for insomnia itself does not exist. All clinical work focused on sexual desire.\\n\\n## How these fit together\\nSingle-compound focus. PT-141 targets the sexual / CNS arousal layer only. If your insomnia profile involves other layers (hormonal, inflammatory, or mechanical), additional compounds would address those separately.\\n\\n## What the evidence actually shows\\nNo randomized trials tested PT-141 for insomnia. Phase 3 RECONNECT trials (two identical studies, ~1,200+ premenopausal women) measured sexual desire and distress scores over 24 weeks. They showed statistically significant improvements in desire domain scores versus placebo but reported no sleep endpoints (source: pubmed.ncbi.nlm.nih.gov/31599840, clinicaltrials.gov NCT02338960 and NCT02333071).\\n\\nSide-effect data from","tokens_in":15126,"tokens_out":2920,"cost":0,"prev":"genesis","hash":"0258fe9c0761eac0dd3137cabfd3bcdf0127ee047cef11bbc6247fb2f1d224be"},{"ts":"2026-07-17T02:41:07.342Z","model":"owner","action":"voxel_divide","prompt":"","input":"pt-141-insomnia","response":"22 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"0258fe9c0761eac0dd3137cabfd3bcdf0127ee047cef11bbc6247fb2f1d224be","hash":"8fd312dfb88a3bf2100ff33f59acc7f50677c761feaeca43353bb8f4053925d8"}],"energy":{"passes":2,"tokens_in":15126,"tokens_out":2920,"tokens_total":18046,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"8fd312dfb88a3bf2100ff33f59acc7f50677c761feaeca43353bb8f4053925d8"},"posted_at":"2026-06-29T21:32:53.772Z","created_at":"2026-06-29T21:32:53.772Z","updated_at":"2026-07-17T02:41:07.342Z","machine":{"shape":"article.machine/v1","slug":"pt-141-insomnia","kind":"article","read":{"human":"https://miscsubjects.com/a/pt-141-insomnia","json":"https://miscsubjects.com/api/articles/pt-141-insomnia","bundle":"https://miscsubjects.com/api/articles/pt-141-insomnia/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":5,"sources":6,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/pt-141-insomnia/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=pt-141-insomnia","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-insomnia\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-insomnia\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/pt-141-insomnia/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"pt-141-insomnia\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/pt-141-insomnia | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/pt-141-insomnia","json":"/api/articles/pt-141-insomnia","markdown":"/api/articles/pt-141-insomnia/bundle?format=markdown","skill":"/api/articles/pt-141-insomnia/skill","topology":"/api/articles/pt-141-insomnia/topology","versions":"/api/articles/pt-141-insomnia/revisions","invocations":"/api/articles/pt-141-insomnia/invocations"},"editorial_review":null,"editorial_audit":{"slug":"pt-141-insomnia","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"a892fd44c8102ee60627927b08f86f5c81ffb8417a77c5abdc6b9b83091680b1","object":{"object_type":"article-object","identity":{"id":"article:pt-141-insomnia","slug":"pt-141-insomnia","title":"PT-141 for Insomnia: Evidence-Graded Review"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/pt-141-insomnia","role":"explain","audience":"human"},"skill":{"route":"/api/articles/pt-141-insomnia/skill","role":"direct behavior","audience":"model","content":"---\nname: pt-141-insomnia\ndescription: Apply the PT-141 for Insomnia: Evidence-Graded Review article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# PT-141 for Insomnia: Evidence-Graded Review\n\nThis Skill is the behavioral expression of [the canonical article](/a/pt-141-insomnia). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/pt-141-insomnia.\n- Read claims and relationships at /api/articles/pt-141-insomnia/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down Insomnia involves disrupted sleep-wake regulation. The hypothalamus helps control both sexual arousal and sleep cycles through shared pathways. When CNS arousal signals stay elevated or misfire at night, falling or stay\n\n## Representations\n\n- Human: /a/pt-141-insomnia\n- JSON: /api/articles/pt-141-insomnia\n- Relationships: /api/articles/pt-141-insomnia/topology\n- History: /api/articles/pt-141-insomnia/revisions\n"},"json":{"route":"/api/articles/pt-141-insomnia","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/pt-141-insomnia/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","pt","141","insomnia"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/pt-141-insomnia/invocations?status=success","failure_events":"/api/articles/pt-141-insomnia/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"pt-141-insomnia","title":"PT-141 for Insomnia: Evidence-Graded Review","body":"## What's breaking down\nInsomnia involves disrupted sleep-wake regulation. The hypothalamus helps control both sexual arousal and sleep cycles through shared pathways. When CNS arousal signals stay elevated or misfire at night, falling or staying asleep becomes harder. No single peptide fixes this directly. Repair would mean restoring balanced signaling in those brain regions rather than forcing sedation.\n\n## Why PT-141 might help you\nPT-141 activates melanocortin receptors (mainly MC4R) in the hypothalamus. This is the same area that processes both sexual motivation and aspects of arousal state.\n\n1. If your insomnia links to under-arousal or flattened motivation during the day that flips into nighttime restlessness, the CNS arousal layer is one possible contributor.\n2. PT-141 is discussed for that layer because it engages central pathways rather than acting as a sedative or masking symptoms.\n3. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue/CNS signaling balance) — not because it masks pain or forces sleep.\n\nHuman data for insomnia itself does not exist. All clinical work focused on sexual desire.\n\n## How these fit together\nSingle-compound focus. PT-141 targets the sexual / CNS arousal layer only. If your insomnia profile involves other layers (hormonal, inflammatory, or mechanical), additional compounds would address those separately.\n\n## What the evidence actually shows\nNo randomized trials tested PT-141 for insomnia. Phase 3 RECONNECT trials (two identical studies, ~1,200+ premenopausal women) measured sexual desire and distress scores over 24 weeks. They showed statistically significant improvements in desire domain scores versus placebo but reported no sleep endpoints (source: pubmed.ncbi.nlm.nih.gov/31599840, clinicaltrials.gov NCT02338960 and NCT02333071).\n\nSide-effect data from the same program lists “trouble sleeping” as a possible reaction (mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route).\n\n## What scientists say\nResearchers describe PT-141 as a melanocortin agonist acting centrally on MC3R/MC4R in the hypothalamus. This mechanism explains effects on sexual motivation. No publications link it to sleep architecture or insomnia treatment. Hypothalamic melanocortin pathways overlap with arousal regulation, but that overlap remains untested for sleep outcomes.\n\n## What people say on Reddit\nAnecdotal reports are mixed and sparse. One thread titled “PT-141 and best sleep ever” describes subjectively deeper rest after dosing. Several users note fatigue or 10–12 hours of sleep the night after injection, sometimes with persistent arousal effects upon waking. Others report restlessness or nausea that interferes with sleep. No consistent pattern of insomnia relief appears across threads (examples: reddit.com/r/Peptidesource/comments/1qdmtus, reddit.com/r/erectiledysfunction/comments/15cmlf0).\n\n## What people say on X\nLimited public discussion. Posts mentioning PT-141 and sleep are rare and usually incidental to libido use. No verified threads or threads with measurable outcomes surfaced in searches.\n\n## What we do not know\n- Whether PT-141 changes sleep latency, efficiency, or architecture in humans.\n- Dose-response relationship for any sleep effect.\n- Long-term impact on insomnia when used repeatedly.\n- Interaction with common insomnia factors such as cortisol rhythm or circadian misalignment.\nAll claims beyond the established sexual-desire indication remain mechanistic or anecdotal.\n\n## Safety and limits\nCommon side effects in trials included nausea, flushing, and headache. “Trouble sleeping” appears in prescribing information. PT-141 carries an FDA approval only for hypoactive sexual desire disorder in premenopausal women. No safety data support its use for insomnia. Individual responses vary widely in anecdotal reports.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/pt-141-insomnia/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No randomized controlled trials have tested PT-141 (bremelanotide) for insomnia or sleep improvement.","section":"What the evidence actually shows","tier":"human","source_ids":["s1","s2"],"source_status":"sourced","why_material":"Establishes absence of direct evidence for the claimed use.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:14:09.291Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Phase 3 RECONNECT trials showed statistically significant improvements in sexual desire scores versus placebo in women with HSDD.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Provides the actual approved indication and strength of evidence.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:14:09.291Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Prescribing information lists trouble sleeping as a possible side effect of bremelanotide.","section":"Safety and limits","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Direct safety signal relevant to insomnia discussion.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":"limitations","who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:14:09.291Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"PT-141 acts as an MC4R agonist in the hypothalamus, a region involved in both sexual arousal and broader arousal state regulation.","section":"Why PT-141 might help you","tier":"mechanistic","source_ids":["s4"],"source_status":"sourced","why_material":"Explains the proposed CNS layer without claiming clinical effect.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:14:09.291Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"Some Reddit users report subjectively improved or prolonged sleep after PT-141 dosing, while others report restlessness or fatigue.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s5","s6"],"source_status":"sourced","why_material":"Documents real-world user observations separate from trials.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:14:09.291Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/31599840/","title":"Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials","quote":"Both studies demonstrated that bremelanotide significantly improved sexual desire and related distress in premenopausal women with hypoactive sexual desire disorder.","summary":"Phase 3 RECONNECT trial results for HSDD; no sleep endpoints reported.","claim_ids":["c1","c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:14:08.815Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"814839b477804ad6c66c888aa86822c1584adb56fec72567a04b0381e73cfd27"},{"id":"s2","type":"clinical_trial","url":"https://clinicaltrials.gov/study/NCT02338960","title":"Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder","quote":"Primary Objective: To evaluate the efficacy of bremelanotide (BMT)... for the treatment of HSDD","summary":"Confirms trial design focused solely on sexual desire.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:14:08.815Z","link_status":"ok","quote_status":"unverified","prev":"814839b477804ad6c66c888aa86822c1584adb56fec72567a04b0381e73cfd27","hash":"3ff336a1821e343c0f352debdbe559b93fcf0dc503cc4932367a1dc961887cd3"},{"id":"s3","type":"medical","url":"https://www.mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route/description/drg-20466805","title":"Bremelanotide (subcutaneous route) - Side effects & dosage","quote":"* trouble sleeping","summary":"Lists trouble sleeping among possible side effects.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:14:08.815Z","link_status":"http_403","quote_status":"unverified","prev":"3ff336a1821e343c0f352debdbe559b93fcf0dc503cc4932367a1dc961887cd3","hash":"5abe74d91d95c0be2c607b4f6b49b53b5c9205e9aa92791d26d5ff6d275a2192"},{"id":"s4","type":"review","url":"https://www.innerbalance.com/p/learn/pt141-for-women/","title":"PT-141 for Women: Complete Guide to Bremelanotide","quote":"PT-141 targets the central nervous system directly, addressing desire at its neurological origin.","summary":"Describes hypothalamic MC4R mechanism.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:14:08.815Z","link_status":"http_429","quote_status":"unverified","prev":"5abe74d91d95c0be2c607b4f6b49b53b5c9205e9aa92791d26d5ff6d275a2192","hash":"07ba452e51ea1a434dda8d37c0f0af9dc20e102d2e211011f71e4be5fc511e2d"},{"id":"s5","type":"reddit","url":"https://www.reddit.com/r/Peptidesource/comments/1qdmtus/pt141_and_best_sleep_ever/","title":"PT-141 and best sleep ever","quote":"PT-141 is great and I take it every 3 days... the effects last...","summary":"User anecdote claiming improved sleep.","claim_ids":["c5"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:14:08.815Z","link_status":"ok","quote_status":"unverified","prev":"07ba452e51ea1a434dda8d37c0f0af9dc20e102d2e211011f71e4be5fc511e2d","hash":"d73163b5dd1d7a9b40781c70389c30730d391440af9d2adf6f6b4f586baf7da2"},{"id":"s6","type":"reddit","url":"https://www.reddit.com/r/erectiledysfunction/comments/15cmlf0/pt141_works_great_but_only_when_sleeping/","title":"PT141 works great but only when sleeping","quote":"I always sleep 12 hours straight after taking it.","summary":"Multiple user reports of altered sleep duration or quality.","claim_ids":["c5"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:14:08.815Z","link_status":"ok","quote_status":"unverified","prev":"d73163b5dd1d7a9b40781c70389c30730d391440af9d2adf6f6b4f586baf7da2","hash":"68b103dde713d10ee3d4549f43841e986c67e735b1ee09fe14e8d6b7f9a3137f"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T01:14:09.941Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"PT-141 for Insomnia: Evidence-Graded Review","register":"source_ledger","body":"## What's breaking down\nInsomnia involves disrupted sleep-wake regulation. The hypothalamus helps control both sexual arousal and sleep cycles through shared pathways. When CNS arousal signals stay elevated or misfire at night, falling or staying asleep becomes harder. No single peptide fixes this directly. Repair would mean restoring balanced signaling in those brain regions rather than forcing sedation.\n\n## Why PT-141 might help you\nPT-141 activates melanocortin receptors (mainly MC4R) in the hypothalamus. This is the same area that processes both sexual motivation and aspects of arousal state.\n\n1. If your insomnia links to under-arousal or flattened motivation during the day that flips into nighttime restlessness, the CNS arousal layer is one possible contributor.\n2. PT-141 is discussed for that layer because it engages central pathways rather than acting as a sedative or masking symptoms.\n3. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue/CNS signaling balance) — not because it masks pain or forces sleep.\n\nHuman data for insomnia itself does not exist. All clinical work focused on sexual desire.\n\n## How these fit together\nSingle-compound focus. PT-141 targets the sexual / CNS arousal layer only. If your insomnia profile involves other layers (hormonal, inflammatory, or mechanical), additional compounds would address those separately.\n\n## What the evidence actually shows\nNo randomized trials tested PT-141 for insomnia. Phase 3 RECONNECT trials (two identical studies, ~1,200+ premenopausal women) measured sexual desire and distress scores over 24 weeks. They showed statistically significant improvements in desire domain scores versus placebo but reported no sleep endpoints (source: pubmed.ncbi.nlm.nih.gov/31599840, clinicaltrials.gov NCT02338960 and NCT02333071).\n\nSide-effect data from the same program lists “trouble sleeping” as a possible reaction (mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route).\n\n## What scientists say\nResearchers describe PT-141 as a melanocortin agonist acting centrally on MC3R/MC4R in the hypothalamus. This mechanism explains effects on sexual motivation. No publications link it to sleep architecture or insomnia treatment. Hypothalamic melanocortin pathways overlap with arousal regulation, but that overlap remains untested for sleep outcomes.\n\n## What people say on Reddit\nAnecdotal reports are mixed and sparse. One thread titled “PT-141 and best sleep ever” describes subjectively deeper rest after dosing. Several users note fatigue or 10–12 hours of sleep the night after injection, sometimes with persistent arousal effects upon waking. Others report restlessness or nausea that interferes with sleep. No consistent pattern of insomnia relief appears across threads (examples: reddit.com/r/Peptidesource/comments/1qdmtus, reddit.com/r/erectiledysfunction/comments/15cmlf0).\n\n## What people say on X\nLimited public discussion. Posts mentioning PT-141 and sleep are rare and usually incidental to libido use. No verified threads or threads with measurable outcomes surfaced in searches.\n\n## What we do not know\n- Whether PT-141 changes sleep latency, efficiency, or architecture in humans.\n- Dose-response relationship for any sleep effect.\n- Long-term impact on insomnia when used repeatedly.\n- Interaction with common insomnia factors such as cortisol rhythm or circadian misalignment.\nAll claims beyond the established sexual-desire indication remain mechanistic or anecdotal.\n\n## Safety and limits\nCommon side effects in trials included nausea, flushing, and headache. “Trouble sleeping” appears in prescribing information. PT-141 carries an FDA approval only for hypoactive sexual desire disorder in premenopausal women. No safety data support its use for insomnia. Individual responses vary widely in anecdotal reports.","claims":[{"id":"c1","text":"No randomized controlled trials have tested PT-141 (bremelanotide) for insomnia or sleep improvement.","section":"What the evidence actually shows","tier":"human","source_ids":["s1","s2"],"source_status":"sourced","why_material":"Establishes absence of direct evidence for the claimed use.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:14:09.291Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Phase 3 RECONNECT trials showed statistically significant improvements in sexual desire scores versus placebo in women with HSDD.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Provides the actual approved indication and strength of evidence.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:14:09.291Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Prescribing information lists trouble sleeping as a possible side effect of bremelanotide.","section":"Safety and limits","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Direct safety signal relevant to insomnia discussion.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":"limitations","who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:14:09.291Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"PT-141 acts as an MC4R agonist in the hypothalamus, a region involved in both sexual arousal and broader arousal state regulation.","section":"Why PT-141 might help you","tier":"mechanistic","source_ids":["s4"],"source_status":"sourced","why_material":"Explains the proposed CNS layer without claiming clinical effect.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:14:09.291Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"Some Reddit users report subjectively improved or prolonged sleep after PT-141 dosing, while others report restlessness or fatigue.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s5","s6"],"source_status":"sourced","why_material":"Documents real-world user observations separate from trials.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:14:09.291Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/31599840/","title":"Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials","quote":"Both studies demonstrated that bremelanotide significantly improved sexual desire and related distress in premenopausal women with hypoactive sexual desire disorder.","link_status":"ok","quote_status":"verified"},{"id":"s2","type":"clinical_trial","url":"https://clinicaltrials.gov/study/NCT02338960","title":"Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder","quote":"Primary Objective: To evaluate the efficacy of bremelanotide (BMT)... for the treatment of HSDD","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"medical","url":"https://www.mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route/description/drg-20466805","title":"Bremelanotide (subcutaneous route) - Side effects & dosage","quote":"* trouble sleeping","link_status":"http_403","quote_status":"unverified"},{"id":"s4","type":"review","url":"https://www.innerbalance.com/p/learn/pt141-for-women/","title":"PT-141 for Women: Complete Guide to Bremelanotide","quote":"PT-141 targets the central nervous system directly, addressing desire at its neurological origin.","link_status":"http_429","quote_status":"unverified"},{"id":"s5","type":"reddit","url":"https://www.reddit.com/r/Peptidesource/comments/1qdmtus/pt141_and_best_sleep_ever/","title":"PT-141 and best sleep ever","quote":"PT-141 is great and I take it every 3 days... the effects last...","link_status":"ok","quote_status":"unverified"},{"id":"s6","type":"reddit","url":"https://www.reddit.com/r/erectiledysfunction/comments/15cmlf0/pt141_works_great_but_only_when_sleeping/","title":"PT141 works great but only when sleeping","quote":"I always sleep 12 hours straight after taking it.","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":15126,"tokens_out":2920,"cost":0.0262075,"prev_hash":"genesis","hash":"0886d4050077d04d8711e72f73c273cee83a360db0c2ac4fc33445fe771caa95"}],"provenance":[{"ts":"2026-06-30T01:14:09.941Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: PT 141 for Insomnia\nSlug: pt-141-insomnia\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"pt-141\",\"name\":\"PT-141\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"pt-141\",\"name\":\"PT-141\",\"section_title\":\"Why PT-141 might help you\",\"layer\":\"sexual / CNS arousal\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **PT-141** → sexual / CNS arousal\",\"section_headings\":[\"What's breaking down\",\"Why PT-141 might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one peptide essay.\",\"Each Why section must use if-then steps from peptide","response":"{\n  \"slug\": \"pt-141-insomnia\",\n  \"title\": \"PT-141 for Insomnia: Evidence-Graded Review\",\n  \"body\": \"## What's breaking down\\nInsomnia involves disrupted sleep-wake regulation. The hypothalamus helps control both sexual arousal and sleep cycles through shared pathways. When CNS arousal signals stay elevated or misfire at night, falling or staying asleep becomes harder. No single peptide fixes this directly. Repair would mean restoring balanced signaling in those brain regions rather than forcing sedation.\\n\\n## Why PT-141 might help you\\nPT-141 activates melanocortin receptors (mainly MC4R) in the hypothalamus. This is the same area that processes both sexual motivation and aspects of arousal state.\\n\\n1. If your insomnia links to under-arousal or flattened motivation during the day that flips into nighttime restlessness, the CNS arousal layer is one possible contributor.\\n2. PT-141 is discussed for that layer because it engages central pathways rather than acting as a sedative or masking symptoms.\\n3. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue/CNS signaling balance) — not because it masks pain or forces sleep.\\n\\nHuman data for insomnia itself does not exist. All clinical work focused on sexual desire.\\n\\n## How these fit together\\nSingle-compound focus. PT-141 targets the sexual / CNS arousal layer only. If your insomnia profile involves other layers (hormonal, inflammatory, or mechanical), additional compounds would address those separately.\\n\\n## What the evidence actually shows\\nNo randomized trials tested PT-141 for insomnia. Phase 3 RECONNECT trials (two identical studies, ~1,200+ premenopausal women) measured sexual desire and distress scores over 24 weeks. They showed statistically significant improvements in desire domain scores versus placebo but reported no sleep endpoints (source: pubmed.ncbi.nlm.nih.gov/31599840, clinicaltrials.gov NCT02338960 and NCT02333071).\\n\\nSide-effect data from","tokens_in":15126,"tokens_out":2920,"cost":0,"prev":"genesis","hash":"0258fe9c0761eac0dd3137cabfd3bcdf0127ee047cef11bbc6247fb2f1d224be"},{"ts":"2026-07-17T02:41:07.342Z","model":"owner","action":"voxel_divide","prompt":"","input":"pt-141-insomnia","response":"22 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"0258fe9c0761eac0dd3137cabfd3bcdf0127ee047cef11bbc6247fb2f1d224be","hash":"8fd312dfb88a3bf2100ff33f59acc7f50677c761feaeca43353bb8f4053925d8"}],"energy":{"passes":2,"tokens_in":15126,"tokens_out":2920,"tokens_total":18046,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"8fd312dfb88a3bf2100ff33f59acc7f50677c761feaeca43353bb8f4053925d8"},"posted_at":"2026-06-29T21:32:53.772Z","created_at":"2026-06-29T21:32:53.772Z","updated_at":"2026-07-17T02:41:07.342Z","machine":{"shape":"article.machine/v1","slug":"pt-141-insomnia","kind":"article","read":{"human":"https://miscsubjects.com/a/pt-141-insomnia","json":"https://miscsubjects.com/api/articles/pt-141-insomnia","bundle":"https://miscsubjects.com/api/articles/pt-141-insomnia/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":5,"sources":6,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/pt-141-insomnia/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=pt-141-insomnia","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-insomnia\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-insomnia\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/pt-141-insomnia/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"pt-141-insomnia\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/pt-141-insomnia | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/pt-141-insomnia","json":"/api/articles/pt-141-insomnia","markdown":"/api/articles/pt-141-insomnia/bundle?format=markdown","skill":"/api/articles/pt-141-insomnia/skill","topology":"/api/articles/pt-141-insomnia/topology","versions":"/api/articles/pt-141-insomnia/revisions","invocations":"/api/articles/pt-141-insomnia/invocations"},"editorial_review":null,"editorial_audit":{"slug":"pt-141-insomnia","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"a892fd44c8102ee60627927b08f86f5c81ffb8417a77c5abdc6b9b83091680b1"}}}